Amdocs (NASDAQ:DOX) Issues FY 2026 Earnings Guidance

Amdocs (NASDAQ:DOX) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 7.270-7.550 for the period, compared to the consensus estimate of 7.110. The company issued revenue guidance of $4.6 billion-$4.8 billion, compared to the consensus revenue estimate of $4.7 billion. Amdocs also updated its Q2 2026 guidance to 1.730-1.790 EPS.

Amdocs Price Performance

Shares of NASDAQ:DOX traded down $6.99 on Tuesday, reaching $74.02. The company’s stock had a trading volume of 3,187,220 shares, compared to its average volume of 890,122. The company has a 50-day simple moving average of $80.37 and a 200 day simple moving average of $82.64. Amdocs has a 52-week low of $73.18 and a 52-week high of $95.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.17 and a current ratio of 1.17. The company has a market cap of $7.99 billion, a P/E ratio of 14.66, a PEG ratio of 1.37 and a beta of 0.40.

Amdocs Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Wednesday, December 31st were issued a dividend of $0.527 per share. The ex-dividend date was Wednesday, December 31st. This represents a $2.11 dividend on an annualized basis and a yield of 2.8%. Amdocs’s payout ratio is presently 41.78%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on DOX. Bank of America decreased their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Stifel Nicolaus cut their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a report on Wednesday, November 12th. Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, January 3rd. Finally, Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $97.00.

Key Amdocs News

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: T‑Mobile extended a strategic multi‑year agreement with Amdocs covering managed services, software development and AI initiatives — a material customer renewal that supports recurring revenue. T‑Mobile strategic agreement
• Positive Sentiment: VIDAA selected Amdocs MarketONE to power OTT subscription and bundled streaming on smart TVs — a product win that could expand MarketONE adoption and monetization opportunities. VIDAA selects MarketONE
• Positive Sentiment: Amdocs launched aOS, an “agentic operating system” aimed at embedding generative AI into telecom operations — a strategic product initiative that could drive long‑term differentiation. Amdocs introduces aOS
• Positive Sentiment: Shareholders approved board proposals at the AGM, including a boosted dividend and expansion of the employee share plan — supportive for income investors and employee alignment. AGM results
• Neutral Sentiment: The company posted press materials, a slide deck and a conference call recording for the quarter — useful for parsing results and management commentary but not a market mover by itself. Press release / slide deck
• Neutral Sentiment: Short‑interest reports in recent feeds show inconsistent/zero values (NaN/0) and days‑to‑cover of 0.0 — the published data appears unreliable and shouldn’t be interpreted as fresh bearish positioning.
• Negative Sentiment: MarketBeat and some market sources reported Amdocs’ quarter at $1.63 EPS, missing consensus (~$1.75) — that reported miss likely triggered immediate selling. MarketBeat earnings report
• Negative Sentiment: Conflicting headlines — Zacks published a report showing an adjusted beat ($1.81) while other outlets showed a $1.63 EPS result — created investor confusion over the company’s actual performance and adjustments, amplifying volatility and downside pressure. Zacks earnings note

Hedge Funds Weigh In On Amdocs

Several large investors have recently made changes to their positions in DOX. Amundi raised its position in shares of Amdocs by 73.0% during the 1st quarter. Amundi now owns 13,778 shares of the technology company’s stock worth $1,217,000 after purchasing an additional 5,816 shares during the last quarter. Millennium Management LLC increased its stake in Amdocs by 458.3% during the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock worth $6,135,000 after buying an additional 55,038 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Amdocs by 12.6% during the first quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock valued at $30,300,000 after acquiring an additional 37,087 shares during the last quarter. Empowered Funds LLC raised its holdings in shares of Amdocs by 12.0% during the first quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock valued at $1,462,000 after acquiring an additional 1,709 shares during the last quarter. Finally, Jane Street Group LLC lifted its position in shares of Amdocs by 195.4% in the first quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock valued at $10,608,000 after acquiring an additional 76,683 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.